NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025.
Publication
, Journal Article
Haddad, RI; Bischoff, L; Applewhite, M; Bernet, V; Blomain, E; Brito, M; Busaidy, NL; Campbell, M; DeLozier, O; Duh, Q-Y; Ehya, H; Grady, E ...
Published in: J Natl Compr Canc Netw
July 2025
The NCCN Guidelines for Thyroid Carcinoma address the management of different types of thyroid carcinoma, including papillary, follicular, oncocytic, medullary, and anaplastic carcinoma. The NCCN Thyroid Carcinoma Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights focus on the panel's most recent recommendations regarding systemic therapies for thyroid carcinoma as well as the supporting clinical data.
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
July 2025
Volume
23
Issue
7
Location
United States
Related Subject Headings
- Thyroid Neoplasms
- Oncology & Carcinogenesis
- Medical Oncology
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Haddad, R. I., Bischoff, L., Applewhite, M., Bernet, V., Blomain, E., Brito, M., … Sliker, B. (2025). NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025. J Natl Compr Canc Netw, 23(7). https://doi.org/10.6004/jnccn.2025.0033
Haddad, Robert I., Lindsay Bischoff, Megan Applewhite, Victor Bernet, Erik Blomain, Maria Brito, Naifa Lamki Busaidy, et al. “NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025.” J Natl Compr Canc Netw 23, no. 7 (July 2025). https://doi.org/10.6004/jnccn.2025.0033.
Haddad RI, Bischoff L, Applewhite M, Bernet V, Blomain E, Brito M, et al. NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025. J Natl Compr Canc Netw. 2025 Jul;23(7).
Haddad, Robert I., et al. “NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025.” J Natl Compr Canc Netw, vol. 23, no. 7, July 2025. Pubmed, doi:10.6004/jnccn.2025.0033.
Haddad RI, Bischoff L, Applewhite M, Bernet V, Blomain E, Brito M, Busaidy NL, Campbell M, DeLozier O, Duh Q-Y, Ehya H, Grady E, Guo T, Haymart M, Hunt JP, Kandeel F, Kotwal A, Lamonica DM, Lorch J, Mandel SJ, Markovina S, Mydlarz W, Nabell L, Raeburn CD, Rezaee R, Ridge JA, Ritter H, Roth MY, Salgado SA, Scheri RP, Shah JP, Sipos JA, Sippel R, Sturgeon C, Wirth LJ, Wong RJ, Worden F, Yeh MW, Darlow S, Cassara CJ, Sliker B. NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025. J Natl Compr Canc Netw. 2025 Jul;23(7).
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
July 2025
Volume
23
Issue
7
Location
United States
Related Subject Headings
- Thyroid Neoplasms
- Oncology & Carcinogenesis
- Medical Oncology
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis